Pisa syndrome without neuroleptic exposure in a patient with Parkinson's disease: Case report
β Scribed by Mattia Gambarin; Angelo Antonini; Giuseppe Moretto; Paolo Bovi; Silvia Romito; Antonio Fiaschi; Michele Tinazzi
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 111 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
We report on a patient affected by Parkinson's disease who developed over a period of a few weeks a tonic deviation of her head, neck, and trunk fitting the typical description of Pisa syndrome (PS). This patient was under stable levodopa and pramipexole treatment and had never been exposed to any psychotropic or antiemetic drugs before or at the time she developed the postural abnormality. Because dopamine transporter imaging revealed bilateral and symmetrical reduction of striatal uptake, we suggest that PS is not primarily related to side differences in dopaminergic denervation or drug exposure. Β© 2005 Movement Disorder Society
π SIMILAR VOLUMES
## Abstract A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom
## Abstract ## Objective Depression is a common neuropsychiatric syndrome in Parkinson's disease (PD), and may be etiologically related to the neurochemical changes accompanying this disease. It is still unclear whether the disturbances of neurotransmitter activities lead to a specific profile of